Bml Capital Management, LLC Top Holdings and 13F Report (2025) About Bml Capital Management, LLCInvestment ActivityBml Capital Management, LLC has $132.18 million in total holdings as of June 30, 2025.Bml Capital Management, LLC owns shares of 24 different stocks, but just 9 companies or ETFs make up 80% of its holdings.Approximately 8.97% of the portfolio was purchased this quarter.About 9.59% of the portfolio was sold this quarter.This quarter, Bml Capital Management, LLC has purchased 27 new stocks and bought additional shares in 10 stocks.Bml Capital Management, LLC sold shares of 3 stocks and completely divested from 5 stocks this quarter.Largest Holdings Atea Pharmaceuticals $27,395,323Third Harmonic Bio $20,766,584Aclaris Therapeutics $20,235,000INSTIL BIO INC $11,141,946ESSA Pharma $7,176,628 Largest New Holdings this Quarter 88160R101 - Tesla $1,654,000 Holding221015100 - Corvus Pharmaceuticals $475,064 Holding Largest Purchases this Quarter ALUMIS INC 1,160,788 shares (about $3.48M)INSTIL BIO INC 118,179 shares (about $2.46M)Tesla 200 shares (about $1.65M)PMV Pharmaceuticals 1,252,388 shares (about $1.33M)KEZAR LIFE SCIENCES INC 227,045 shares (about $1.04M) Largest Sales this Quarter Connect Biopharma 271,674 shares (about $266.24K)Lisata Therapeutics 7,039 shares (about $20.41K)Elevation Oncology 500 shares (about $183.55) Sector Allocation Over TimeMap of 500 Largest Holdings ofBml Capital Management, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorAVIRAtea Pharmaceuticals$27,395,3230.0%7,609,81220.7%MedicalTHRDThird Harmonic Bio$20,766,5840.0%3,824,41715.7%MedicalACRSAclaris Therapeutics$20,235,0000.0%14,250,00015.3%MedicalINSTIL BIO INC$11,141,946$2,461,669 ▲28.4%534,8998.4%COM NEWEPIXESSA Pharma$7,176,6280.0%4,221,5465.4%MedicalORMPOramed Pharmaceuticals$6,937,319$140,636 ▲2.1%3,083,2535.2%MedicalADVERUM BIOTECHNOLOGIES INC$6,573,681$677,699 ▲11.5%3,057,5265.0%COM NEWIKENA ONCOLOGY INC$5,400,337$427,861 ▲8.6%4,030,1024.1%COMPMVPPMV Pharmaceuticals$5,300,000$1,327,531 ▲33.4%5,000,0004.0%MedicalALUMIS INC$3,631,245$3,482,364 ▲2,339.0%1,210,4152.7%COMKEZAR LIFE SCIENCES INC$2,909,138$1,039,866 ▲55.6%635,1832.2%COM NEWLVTXLAVA Therapeutics$2,601,205$13,200 ▲0.5%1,970,6102.0%MedicalMISTMilestone Pharmaceuticals$2,204,0170.0%1,136,0911.7%MedicalELEVElevation Oncology$2,162,378$184 ▼0.0%5,890,4341.6%MedicalCNTBConnect Biopharma$1,785,127$266,241 ▼-13.0%1,821,5581.4%MedicalTSLATesla$1,654,000$1,654,000 ▲New Holding2001.3%Auto/Tires/TrucksASTCAstrotech$1,272,8680.0%220,4101.0%AerospaceATHAAthira Pharma$975,661$9,060 ▲0.9%3,230,6670.7%MedicalLSTALisata Therapeutics$608,272$20,407 ▼-3.2%209,8140.5%MedicalCRVSCorvus Pharmaceuticals$475,064$475,064 ▲New Holding118,7660.4%MedicalTURNSTONE BIOLOGICS CORP$396,1160.0%1,103,3860.3%COMVTGNVistaGen Therapeutics$300,0000.0%150,0000.2%MedicalHLVXHilleVax$182,907$141,595 ▲342.7%91,9130.1%MedicalVRCAVerrica Pharmaceuticals$92,5830.0%174,6510.1%MedicalANTX(ANTX)$0$7,819,228 ▼-100.0%00.0%MedicalAADIAadi Bioscience$0$3,364,636 ▼-100.0%00.0%MedicalSAGESage Therapeutics$0$1,074,005 ▼-100.0%00.0%MedicalNXTCNextCure$0$131,379 ▼-100.0%00.0%MedicalACHLAchilles Therapeutics$0-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access